Weill Cornell Medicine
New York, New York, United States
Dr. Allan is an Associatet Professor of Clinical Medicine in the Division of Hematology and Medical Oncology at Weill Cornell Medicine. Dr. Allan obtained his medical degree from Saint Louis University in Saint Louis, Missouri.
In 2009, Dr. Allan moved to New York to train at New York-Presbyterian Hospital, Weill Cornell Medicine, where he completed his residency and hematology and medical oncology fellowship.
Upon completion of training Dr. Allan joined the lymphoma faculty in the Division of Hematology and Oncology. Dr. Allan treats all lymphoid malignancies and has a particular interest in improving therapies for patients with CLL and Richter’s Syndrome, which is the focus of his research.
Session XIII: BTKi as a Target
Saturday, October 21, 2023
7:30 AM – 9:15 AM ET
Ibrutinib and CAPTIVATE Data Updates
Saturday, October 21, 2023
7:40 AM – 8:00 AM ET
Panel Discussion: BTKi: Compare and Contrast Efficacy and Toxicity and Post-Session Audience Survey
Saturday, October 21, 2023
9:00 AM – 9:15 AM ET
Session XV: What, When and How to Use our New Armamentarium
Saturday, October 21, 2023
11:20 AM – 1:20 PM ET
Saturday, October 21, 2023
11:50 AM – 12:10 PM ET
Saturday, October 21, 2023
1:00 PM – 1:20 PM ET
Session XVI: Case Discussions in CLL
Saturday, October 21, 2023
2:35 PM – 3:15 PM ET
Saturday, October 21, 2023
2:35 PM – 3:15 PM ET